Investment Summary |
|
|---|---|
| Date | 2020-10-16 |
| Target | Dren Bio |
| Sector | Life Science |
| Investor(s) |
HBM Partners
BVF Partners |
| Deal Type | Venture |
SEARCH BY
| Category | Private Equity Firm |
|---|---|
| Founded | 2001 |
| PE ASSETS | 2.1B USD |
| Size | Large |
| Type | Sector Focused |
HBM Partners is a private investment firm focused on investing in entrepreneurial biopharma and other healthcare-related companies in Europe, North America, India and other Emerging Markets. HBM looks to invest $5 to $50 million per transaction and will consider private and public companies. HBM Partners was established in 2001 and is headquartered in Zug, Switzerland.
| DEAL STATS | # |
|---|---|
| Overall | 44 of 65 |
| Sector: Life Science M&A | 37 of 56 |
| Type: Venture M&A Deals | 34 of 52 |
| State: California M&A | 14 of 18 |
| Country: United States M&A | 29 of 44 |
| Year: 2020 M&A | 14 of 17 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2020-10-09 |
Everest Medicines
Shanghai, China Everest Medicines is a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products that address critical unmet medical needs for patients in Greater China and other Asian markets. Everest Medicines was founded in 2017 and is based in Shanghai, China. |
Sell | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2020-11-24 |
Monte Rosa Therapeutics
Boston, Massachusetts, United States Monte Rosa Therapeutics is a biotechnology company developing molecular glues to degrade disease-causing proteins. The company has developed a platform to rationally design small molecules that reprogram ubiquitin ligases to eliminate disease drivers previously deemed undruggable. The company’s drug discovery platform combines diverse and proprietary chemical libraries of small molecule protein degraders with in-house proteomics, structural biology, machine learning-based target selection, and computational chemistry capabilities to predict and obtain protein degradation profiles. Monte Rosa Therapeutics was founded in 2018 and is based in Boston, Massachusetts. |
Buy | - |
BVF Partners LP is a private investment firm focused on providing long-term investments in small-cap public biotechnology companies. Prospective transaction types include management buyouts, recapitalizations, and venture. BVF Partners was formed in 1993 and is based in San Francisco, California.
| DEAL STATS | # |
|---|---|
| Overall | 3 of 3 |
| Sector: Life Science M&A | 3 of 3 |
| Type: Venture M&A Deals | 2 of 2 |
| State: California M&A | 2 of 2 |
| Country: United States M&A | 3 of 3 |
| Year: 2020 M&A | 2 of 2 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2020-09-14 |
Eledon
Irvine, California, United States Eledon is a clinical stage biotechnology company using its expertise in targeting the CD40L pathway to develop potential treatments for people requiring an organ or cell-based transplant, and for people with autoimmune and neurodegenerative disease. Eledon is based in Irvine, California. |
Buy | - |
